Bank of New York Mellon’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,233
Closed -$8.6K 4380
2023
Q1
$8.6K Sell
1,233
-35
-3% -$306 ﹤0.01% 4364
2022
Q4
$11.7K Hold
1,268
﹤0.01% 4409
2022
Q3
$15K Buy
+1,268
New +$18.6K ﹤0.01% 4478
2020
Q2
Sell
-10,452
Closed -$1.14M 4077
2020
Q1
$1.14M Buy
10,452
+3,712
+55% +$663K ﹤0.01% 2884
2019
Q4
$1.75M Sell
6,740
-323
-5% -$120K ﹤0.01% 2897
2019
Q3
$3.72M Buy
7,063
+469
+7% +$347K ﹤0.01% 2424
2019
Q2
$6.19M Buy
6,594
+108
+2% +$109K ﹤0.01% 2224
2019
Q1
$7.05M Sell
6,486
-4,462
-41% -$3.99M ﹤0.01% 2164
2018
Q4
$6.52M Buy
+10,948
New +$8.07M ﹤0.01% 2139

Other funds holding ACB

Bank of New York Mellon's ACB Position: Q2 2023 in Review

Bank of New York Mellon sold out of Aurora Cannabis (ACB) in Q2 2023, closing a stake of 1,233 shares — an estimated $8.6K sold.

Bank of New York Mellon first reported a position in ACB in Q4 2018 and held it in 9 quarters. The position peaked at $7.05M in Q1 2019. 195 funds tracked by Wall St. Rank hold ACB as of Q2 2023.

  • Bank of New York Mellon reported no remaining Aurora Cannabis position as of Q2 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 1,233 Aurora Cannabis shares in Q2 2023, an estimated $8.6K.
  • Bank of New York Mellon first reported a position in Aurora Cannabis in Q4 2018 and held it in 9 quarters.
  • Bank of New York Mellon's Aurora Cannabis position peaked at $7.05M in Q1 2019.
  • 195 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2023.

Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.